News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
246 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27455)
Month
January (4345)
February (4356)
March (4475)
April (4721)
May (4999)
June (4103)
July (3643)
August (3329)
September (4039)
October (5055)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Drug Development
Merck’s Keytruda Fails in Late-Stage HCC Trial
Keytruda failed to show a statistical significance in overall survival and progression free survival in the Phase III trial.
February 20, 2019
·
2 min read
·
Alex Keown
Business
ICON Reports Fourth Quarter and Full Year 2018 Results
2019 outlook reaffirmed with revenue guidance in the range of $2,735 - $2,835 million and earnings per share guidance in the range of $6.69 – $6.89 a year over year increase of 9.9% - 13.1%.
February 20, 2019
·
12 min read
Policy
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy
Applications of the treatment will expand to different indications in need to regenerative therapeutic strategies, including scar removal, burns, and pressure/diabetic foot ulcers
February 20, 2019
·
3 min read
Business
Year-end Report January 1 - December 31, 2018
“We summarize 2018 and conclude: RaySearch stands strong. Order intake rose by 19 percent and RayCare has been introduced into clinical use”
February 20, 2019
·
5 min read
Business
InDex Pharmaceuticals Holding AB (publ) Year end Report 2018
Continued focus on the patient recruitment for the CONDUCT study
February 20, 2019
·
5 min read
Business
Cold Rescue Elements the Perfect Antidote to the Winter Cold Season
The cold season, which begins in late August and continues until March or April, may be due to schools opening, the colder weather or just because people spend more time indoors.
February 20, 2019
·
2 min read
Business
Reduce ‘Winter Tiredness’ by Using Reon Revive
Americans from coast-to-coast are beginning to see the benefits of Reon Revive, the easy-to-use powder formula that offers an easy and effective alternative to energy drinks or coffee.
February 20, 2019
·
1 min read
Deals
Weekend Unlimited Completes Acquisition Of Jamaican Assets
With Tier-3 Cultivator’s Licence, Jamaican tourism and export markets to be active in Q2, 2019
February 20, 2019
·
4 min read
Business
GENSPEED Biotech: Novel Point-of-Care Testing Technology Enables Rapid Test for Medical Risk Classification
Austrian GENSPEED Biotech GmbH and Virogates A/S have commenced a partnership to develop a rapid test for the risk classification of acute and chronic patients on site.
February 20, 2019
·
2 min read
Business
Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China
Owlstone Medical Ltd., a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital, announced a collaboration to conduct a clinical trial into the early detection of lung cancer with support from the Li Ka Shing Foundation.
February 20, 2019
·
2 min read
1 of 25
Next